Jakub Hlavka

Assistant Professor

Masaryk University

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jakub Hlavka is an Assistant Professor at Masaryk University in the Czech Republic. His research areas include bioethics in healthcare, Alzheimer's disease treatment paradigms, and the economic implications of the COVID-19 pandemic. He has published several articles addressing both the perceptions of health care stakeholders during the pandemic and innovative approaches to access disease-modifying therapies for Alzheimer's disease.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Andrii Parkhomenko

University of Southern California

UNITED STATES

View details

Fyodor Alexeevich Kondrashov

Professor

Okinawa Institute of Science and Technology Graduate University

JAPAN

View details

Katie Byrd

University of Southern California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jakub Hlavka

Research Interests

Contact this professor

About

Articles (12)

Exploring the Impact of COVID-19 Restrictions on Nursing Home Residents’, Families’, and Staff’s Perceptions of Bioethical Principles: A Qualitative Study

Emerging Alzheimer's disease treatment paradigms: A late‐stage clinical trial review

Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans

Macroeconomic consequences of the COVID-19 pandemic

Access to Disease-Modifying Alzheimer's Therapies: Addressing Possible Challenges Using Innovative Payment Models

Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers

Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge

Crosswalk between the Mini-Mental State Examination and the Telephone Interview for Cognitive Status (TICS-27/30/40)

Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials

Remote opportunities for scholars in Ukraine

Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review

The economics of alternative payment models for pharmaceuticals

Collaborators (3)

Andrii Parkhomenko

Fyodor Alexeevich Kondrashov

Katie Byrd

Make your next move.